Globally, the incidence of sepsis and septic shock has increased over the past decade. The associated morbidity and mortality remain alarmingly high, ranging from 20% to 40% depending on disease severity (
1). Over the past 2 decades, various guidelines and protocols have been developed and updated for the management of sepsis and septic shock. These guidelines commonly recommend the early use of broad-spectrum antibiotics, as numerous previous studies have consistently demonstrated that reducing the delay in initiating effective antibiotic treatment can lower mortality in patients (
2,
3).
Sepsis is a highly heterogeneous syndrome. Given differences in pathophysiological mechanisms, epidemiological patterns, and therapeutic outcomes, patients with culture-negative sepsis likely have distinct characteristics compared with those with culture-positive sepsis. In this study, 150 patients with sepsis admitted to the ICU were included, and several findings supported these differences.
The present study showed that 42.7% of patients with sepsis had negative culture results. Similar findings were reported in the single-center study by Kim et al., in which approximately 41% of patients with septic shock had negative culture outcomes (
4). In the study by Phua et al., 41.5% of patients with sepsis had negative culture results, which is consistent with the present findings (
5). Multicenter studies have shown that the percentage of culture-negative severe sepsis among ICU patients varies by region, with reported rates of 28% in North America, 35% in Spain, and 48% in Canada (
8,
9). In the United States, nearly half of patients hospitalized for sepsis had negative culture results (
10). Taken together, the present study and similar research indicate that patients with septic shock often have negative culture results.
A recent worldwide retrospective analysis spanning 10 years corroborated this finding and showed that the proportion of patients with severe sepsis and negative culture results increased by approximately 28% each year (11).
Multiple factors contribute to the increasing frequency of culture-negative results. One important factor is the administration of antibiotics within the 48 hours before testing (
12). The widespread accessibility of antibiotics, which are commonly used through self-medication or empirical prescription in clinical practice, frequently results in exposure to these agents before sepsis develops. In addition, sepsis caused by nontraditional pathogens, including viruses and fungi, has increased (
13). Infections caused by these organisms may not be accurately detected using conventional culture methods with blood, urine, stool, and pus specimens. For example, sputum cultures often have low detection rates, whereas bronchial lavage increases the likelihood of identifying pathogens (
14). Recent studies using polymerase chain reaction (PCR) techniques have shown that DNA from various organisms can be rapidly identified in the blood of patients with sepsis. This method enables the detection of clinically important fungi and bacteria that often remain undetected in traditional blood cultures (
15). Patients diagnosed with sepsis who do not have detectable pathogens may nevertheless develop the syndrome due to noninfectious causes, such as metabolic disturbances, inflammatory disorders, adverse drug reactions, or malignancies (
16).
Although culture-negative sepsis is frequently observed, studies addressing outcomes in this patient population remain limited. This study evaluated several outcomes, including clinical status, hospital and ICU lengths of stay, duration of mechanical ventilation, and mortality, in the 2 study groups. The findings showed that, although the need for supplemental oxygen was comparable between the groups, patients with culture-positive sepsis had a significantly longer duration of intubation than those with culture-negative sepsis. Consequently, patients with culture-negative sepsis had shorter ICU and hospital stays. Furthermore, hospital mortality was substantially higher among patients with culture-positive sepsis than among those with culture-negative sepsis (41% vs. 9.7%). In the study by Phua et al., findings related to hospital stay duration and mortality were similar to those of the present study. However, after adjustment for confounders such as medical history and patient age, Phua et al. found no significant difference in mortality between the groups (
5).
In the present study, after controlling for age, sex, APACHE II score, CRP concentration, and diastolic blood pressure in the multivariable logistic regression analysis, culture-positive sepsis did not remain independently associated with in-hospital mortality. However, age remained an independent predictor of in-hospital mortality. Li et al. conducted a comprehensive analysis with results that differed from those of the present study, particularly regarding hospital mortality and ICU length of stay, as these outcomes were similar between the 2 groups. However, the duration of mechanical ventilation and overall hospital stay were longer in patients with positive cultures, corroborating the outcomes observed in the present study (
17). In the study by Kim et al., both hospital mortality and 90-day mortality were analyzed, and no significant differences in mortality rates were observed between the 2 groups (
4). In a previous multicenter study by Brun-Buisson et al., which contrasts with the findings of the present study, no significant difference in mortality was observed between 310 patients with culture-negative severe sepsis and 742 patients with culture-positive severe sepsis (
19). In a European ICU study, ICU mortality rates were comparable between the 2 groups, at 40% and 39%, respectively (
18). In contrast to the present study and most investigations in this area, Gupta et al. reported increased mortality among patients with culture-negative severe sepsis (
11). One possible explanation for this finding is the absence of adequate protocols for administering antibiotic treatment to patients with negative cultures.
Variation in findings across studies can generally be attributed to differences in patient demographics, sources of infection, and levels of bacterial resistance to antibiotics. For instance, the present study focused on a younger population (mean age, 41 years compared with 63 years) and found a lower percentage of comorbid conditions (14% vs. 45%) than the retrospective study conducted by Phua et al. Furthermore, infection sites differed notably between the studies. Given that sepsis is a heterogeneous syndrome, infection sites associated with specific pathogens may have distinct clinical characteristics (
5).
A multicenter prospective study conducted in Japan provided evidence that the clinical characteristics and outcomes of patients with severe sepsis and septic shock vary according to the source of infection (
20). A prior retrospective analysis indicated that patients with pulmonary and intra-abdominal infections who had positive cultures had worse outcomes (
21).
Furthermore, the specific organism implicated in sepsis can significantly influence the clinical trajectory and prognosis. For example, in the study by Phua et al., among patients with culture-positive results, the presence of
Pseudomonas aeruginosa was independently associated with an increased risk of mortality (
5). The spectrum of pathogenic organisms varies substantially across hospital settings. In the present study, Acinetobacter was more prevalent than other pathogens. In addition, antibiotic resistance patterns also vary depending on the specific setting analyzed.
5.1. Study Limitations
This study has several limitations. First, sepsis was categorized into 2 main groups based on whether pathogenic microorganisms were identified; however, these categories may encompass multiple diagnostic groups. As discussed, the group without detectable pathogens likely included patients with nonbacterial forms of sepsis and possibly some patients without sepsis. Second, the absence of microbial growth in some cultures may have been attributable to inadequate sample collection. Third, because this study was conducted in a single medical ICU, the generalizability of the findings to other ICU settings may be limited. Finally, given the observational study design, potential unadjusted and unmeasured variables may have influenced the outcomes and interpretation of the findings.
5.2. Conclusions
The present study identified notable differences between patients with culture-negative and culture-positive sepsis. At admission, patients in the culture-negative group had better vital signs, including higher diastolic blood pressure, as well as lower APACHE II scores. In addition, this group had shorter ICU stays, shorter overall hospital stays, and shorter durations of mechanical ventilation. Mortality rates were also lower in the culture-negative group than in the culture-positive group.